Entity > Corporation > US > New York City New York > Emmaus Life Sciences
About Emmaus Life Sciences
Emmaus Life Sciences, Inc. is a biopharmaceutical company. Emmaus Life Sciences, Inc. focuses on rare and orphan diseases, such as sickle cell disease.
Emmaus Life Sciences, Inc. Offers Products For The Treatment Of Sickle Cell Disease: Emmaus Life Sciences, Inc. is in clinical development of a patented experimental treatment approach of an orally administered pharmaceutical grade L-glutamine to treat some of the symptoms of sickle cell disease (SCD). Emmaus Life Sciences, Inc.'s lead commercial product is Endari®. The product candidate showed positive clinical results in the completed Phase 3 clinical trial for sickle cell anaemia and sickle SS0 thalassemia.
Emmaus Life Sciences, Inc.’s Founding and Headquarters: Emmaus Life Sciences, Inc. was founded in 2000 by Yutaka Niihara, M.D., M.P.H. Emmaus Life Sciences, Inc. is currently headquartered in Torrance, California, USA.
Industry:
More information about Emmaus Life Sciences
| Company Attribute | Value |
| Name | Emmaus Life Sciences |
| Url | emmausmedical |
Emmaus Life Sciences
New York City, US
24 Apr 2024
Emmaus Life Sciences
EMI Holding, Inc. (Pharmaceutical company)
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
-
Stock price : EMMA (OTCMKTS) $0.09 0.00 (0.00%)Apr 19, 9:37 AM EDT - Disclaimer
-
Headquarters : Torrance, CA
-
Subsidiaries : Emmaus Medical, MYnd Analytics California, 8 more
-
Founded : 1987